Translocation between chromosome 5q35 and chromosome 11q13 - An unusual cytogenetic finding in a primary refractory acute myeloid leukemia

Clinical and Laboratory Haematology

Volumn 28, Issue 3, 2006, Pages 160-163

  Wang, T F ^a   Horsley, S W ^b   Lee, K F ^c   Chu, S C ^a   Li, C C ^a   Kao, R H ^a  

^a BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c TZU CHI UNIVERSITY   (Taiwan)

Author keywords

Acute myeloid leukemia; Chromosome 11; Chromosome 5; Translocation

Indexed keywords

CD19 ANTIGEN; CYTARABINE; IDARUBICIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; B LYMPHOCYTE; CASE REPORT; CHROMOSOME 11Q; CHROMOSOME 5Q; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION; CYTOGENETICS; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; MALE; MLL GENE; NSD1 GENE; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 5; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; TRANSLOCATION, GENETIC;

EID: 33646717073     PISSN: 01419854     EISSN: 13652257     Source Type: Journal    
DOI: 10.1111/j.1365-2257.2006.00770.x     Document Type: Article

References (26)

1. Ball E.D. Davis R.B. Griffin J.D. Mayer R.J. Davey F.R. Arthur D.C. Wurster-Hill D. Noll W. Elghetany M.T. Allen S.L. Rai K. Lee E.J., Schiffer C.A. Bloomfield C.D. 1991 Prognostic value of lymphocyte surface markers in acute myeloid leukemia. Blood 77, 2242 2250.
2. van den Berg E. Dijkhuizen T. Storkel S. de la Riviere G.B. Dam A. Mensink H.J. Oosterhuis J.W. de Jong B. 1995 Chromosomal changes in renal oncocytomas. Evidence that t(5;11)(q35;q13) may characterize a second subgroup of oncocytomas. Cancer Genetics and Cytogenetics 79, 164 168.
3. Bosch F. Jares P. Campo E. Lopez-Guillermo A. Piris M.A. Villamor N. Tassies D. Jaffe E.S. Montserrat E. Rozman C. Cardesa A. 1994 PRAD-1/cyclin D1 gene overexpression in chronic lymphoproliferative disorders: a highly specific marker of mantle cell lymphoma. Blood 84, 2726 2732.
4. Brown J. Jawad M. Twigg S.R. Saracoglu K. Sauerbrey A. Thomas A.E. Eils R. Harbott J. Kearney L. 2002 A cryptic t(5;11)(q35;p15.5) in 2 children with acute myeloid leukemia with apparently normal karyotypes, identified by a multiplex fluorescence in situ hybridization telomere assay. Blood 99, 2526 2531.
5. Byrd J.C. Mrozek K. Dodge R.K. Carroll A.J. Edwards C.G. Arthur D.C. Pettenati M.J. Patil S.R. Rao K.W. Watson M.S. Koduru P.R. Moore J.O. Stone R.M. Mayer R.J. Feldman E.J. Davey F.R. Schiffer C.A. Larson R.A. Bloomfield C.D. 2002 Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461). Blood 100, 4325 4336.
6. Del Poeta G. Stasi R. Venditti A. Suppo G. Aronica G. Bruno A. Masi M. Tabilio A. Papa G. 1994 Prognostic value of cell marker analysis in de novo acute myeloid leukemia. Leukemia 8, 388 394.
7. Drexler H.G. Thiel E. Ludwig W.D. 1993 Acute myeloid leukemias expressing lymphoid-associated antigens: diagnostic incidence and prognostic significance. Leukemia 7, 489 498.
8. Grimwade D. Walker H. Oliver F. Wheatley K. Harrison C. Harrison G. Rees J. Hann I. Stevens R. Burnett A. Goldstone A. 1998 The importance of diagnostic cytogenetics on outcome in AML: analysis of 1612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood 92, 2322 2333.
9. Itoh M. Okazaki T. Tashima M. Sawada H. Uchiyama T. 1999 Acute myeloid leukemia with t(5;11): two case reports. Leukemia Research 23, 677 680.
10. Jaju R.J. Haas O.A. Neat M. Harbott J. Saha V. Boultwood J. Brown J.M. Pirc-Danoewinata H. Krings B.W. Muller U. Morris S.W. Wainscoat J.S. Kearney L. 1999 A new recurrent translocation, t(5;11)(q35;p15.5), associated with del(5q) in childhood acute myeloid leukemia. The UK Cancer Cytogenetics Group (UKCCG). Blood 94, 773 780.
11. Jaju R.J. Fidler C. Haas O.A. Strickson A.J. Watkins F. Clark K. Cross N.C. Cheng J.F. Aplan P.D. Kearney L. Boultwood J. Wainscoat J.S. 2001 A novel gene, NSD1, is fused to NUP98 in the t(5;11)(q35;p15.5) in de novo childhood acute myeloid leukemia. Blood 98, 1264 1267.
12. Jhang J.S. Narayan G. Murty V.V. Mansukhani M.M. 2004 Renal oncocytomas with 11q13 rearrangements: cytogenetic, molecular, and immunohistochemical analysis of cyclin D1. Cancer Genetics and Cytogenetics 149, 114 119.
13. Khalidi H.S. Medeiros L.J. Chang K.L. Brynes R.K. Slovak M.L. Arber D.A. 1998 The immunophenotype of adult acute myeloid leukemia: high frequency of lymphoid antigen expression and comparison of immunophenotype, French-American-British classification, and karyotypic abnormalities. American Journal of Clinical Pathology 109, 211 220.
14. Lammie G.A. Peters G. 1991 Chromosome 11q13 abnormalities in human cancer. Cancer Cells 3, 413 420.
15. Lauria F. Raspadori D. Ventura M.A. Rondelli D. Testoni N. Tosi P. Michieli M. Damiani D. Motta M.R. Tura S. 1995 The presence of lymphoid-associated antigens in adult acute myeloid leukemia is devoid of prognostic relevance. Stem Cells 13, 428 434.
16. Le Beau M.M. Espinosa R. 3rd. Neuman W.L. Stock W. Roulston D. Larson R.A. Keinanen M. Westbrook C.A. 1993 Cytogenetic and molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases. Proceedings of the National Academy of Sciences of the United States of America 90, 5484 5488.
17. Maeda K. Chung Y.S. Kang S.M. Ogawa M. Onoda N. Nakata B. Nishiguchi Y. Ikehara T. Okuno M. Sowa M. 1997 Overexpression of cyclin D1 and p53 associated with disease recurrence in colorectal adenocarcinoma. International Journal of Cancer 74, 310 315.
18. Michalides R.J. van Veelen N.M. Kristel P.M. Hart A.A. Loftus B.M. Hilgers F.J. Balm A.J. 1997 Overexpression of cyclin D1 indicates a poor prognosis in squamous cell carcinoma of the head and neck. Archives of Otolaryngology - Head and Neck Surgery 123, 497 502.
19. Mitelman F. 1994 Catalog of Chromosome Aberrations in Cancer. Wiley-Liss, New York.
20. Ott M.M. Ott G. Kuse R. Porowski P. Gunzer U. Feller A.C. Muller-Hermelink H.K. 1994 The anaplastic variant of centrocytic lymphoma is marked by frequent rearrangements of the bcl-1 gene and high proliferation indices. Histopathology 24, 329 334.
21. Panarello C. Rosanda C. Morerio C. 2002 Cryptic translocation t(5;11)(q35;p15.5) with involvement of the NSD1 and NUP98 genes without 5q deletion in childhood acute myeloid leukemia. Genes, Chromosomes and Cancer 35, 277 281.
22. Presti J.C., Jr. Rao P.H. Chen Q. Reuter V.E. Li F.P. Fair W.R. Jhanwar S.C. 1991 Histopathological, cytogenetic, and molecular characterization of renal cortical tumors. Cancer Research 51, 1544 1552.
23. Rimokh R. Berger F. Bastard C. Klein B. French M. Archimbaud E. Rouault J.P. Santa Lucia B. Duret L. Vuillaume M. Coiffier B., Bryon P.A. Magaud J.P. 1994 Rearrangement of CCND1 (BCL1/PRAD1) 3′ untranslated region in mantle-cell lymphomas and t(11q13)-associated leukemias. Blood 83, 3689 3696.
24. Shinozaki H. Ozawa S. Ando N. Tsuruta H. Terada M. Ueda M. Kitajima M. 1996 Cyclin D1 amplification as a new predictive classification for squamous cell carcinoma of the esophagus, adding gene information. Clinical Cancer Research 2, 1155 1161.
25. Slovak M.L. Kopecky K.J. Cassileth P.A. Harrington D.H. Theil K.S. Mohamed A. Paietta E. Willman C.L. Head D.R. Rowe J.M. Forman S.J. Appelbaum F.R. 2000 Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study. Blood 96, 4075 4083.
26. Wong K.F. 1999 11q13 is a cytogenetically promiscuous site in hematologic malignancies. Cancer Genetics and Cytogenetics 113, 93 95.